Cutaneous melanoma is a malignancy arising from melanocytes of the skin. Incidence rates
are rising, particularly in White populations. Cutaneous melanoma is typically driven by …

Background Melanoma metastasis to distant sites is associated with diminished survival
rates and poor prognosis. Except of Breslow thickness and ulceration that are currently used …

Background Cutaneous squamous cell carcinoma (cSCC) is the second most common
cancer worldwide with relatively low metastatic potential (2–5%). Developments in …

Background Many patients with low-stage cutaneous melanoma will experience tumor
recurrence, metastasis, or death, and many higher staged patients will not. Objective To …

Amelanotic melanoma (AM) is a subtype of cutaneous melanoma with little or no pigment on
visual or histopathologic examination and makes up approximately 2% of melanoma cases …

Simple Summary More than 40% of patients initially diagnosed with 'low risk'(stage I–II)
melanoma eventually develop melanoma recurrence or die as a result of melanoma. While …

Objectives Checkpoint inhibitors pneumonitis (CIP) is one of the most lethal adverse events
in non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors …

Biomarkers help to inform the clinical management of patients with melanoma. For patients
with clinically localised primary melanoma, biomarkers can help to predict post-surgical …

Background Pathological complete response (pCR) is considered a surrogate for favorable
survival in breast cancer (BC) patients treated with neoadjuvant chemotherapy (NACT) …

Objectives To identify prognostic models for melanoma survival, recurrence and metastasis
among American Joint Committee on Cancer stage I and II patients postsurgery; and …